PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 16, 2018Canadian Journal of Gastroenterology and Hepatology34 citationsOpen Access

Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials

AIAndrea IannoneMRMarinella RuospoGWGermaine Wong

Key Points

Key points are not available for this paper at this time.

Abstract

Mesalazine may reduce recurrences in symptomatic uncomplicated diverticular disease. There is uncertainty on the effect of mesalazine in achieving diverticular disease remission. Mesalazine may not prevent acute diverticulitis in symptomatic uncomplicated diverticular disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Iannone et al. (2018) studied this question.

synapsesocial.com/papers/69d759addf21310ab048f697https://doi.org/10.1155/2018/5437135
Ask AI
Helpful
Bookmark
Share
View Full Paper